27794108|t|FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders
27794108|a|To validate new mitochondrial myopathy serum biomarkers for diagnostic use. We analyzed serum FGF21 (S-FGF21) and GDF15 from patients with (1) mitochondrial diseases and (2) nonmitochondrial disorders partially overlapping with mitochondrial disorder phenotypes. We (3) did a meta-analysis of S-FGF21 in mitochondrial disease and (4) analyzed S-Fgf21 and skeletal muscle Fgf21 expression in 6 mouse models with different muscle - manifesting mitochondrial dysfunctions. We report that S-FGF21 consistently increases in primary mitochondrial myopathy, especially in patients with mitochondrial translation defects or mitochondrial DNA (mtDNA) deletions (675 and 347 pg/mL, respectively; controls: 66 pg/mL, p < 0.0001 for both). This is corroborated in mice (mtDNA deletions 1,163 vs 379 pg/mL, p < 0.0001). However, patients and mice with structural respiratory chain subunit or assembly factor defects showed low induction (human 335 pg/mL, p < 0.05; mice 335 pg/mL, not significant). Overall specificities of FGF21 and GDF15 to find patients with mitochondrial myopathy were 89.3% vs 86.4%, and sensitivities 67.3% and 76.0%, respectively. However, GDF15 was increased also in a wide range of nonmitochondrial conditions. S-FGF21 is a specific biomarker for muscle - manifesting defects of mitochondrial translation, including mitochondrial transfer-RNA mutations and primary and secondary mtDNA deletions, the most common causes of mitochondrial disease. However, normal S-FGF21 does not exclude structural respiratory chain complex or assembly factor defects, important to acknowledge in diagnostics. This study provides Class III evidence that elevated S-FGF21 accurately distinguishes patients with mitochondrial myopathies from patients with other conditions, and FGF21 and GDF15 mitochondrial myopathy from other myopathies.
27794108	0	5	FGF21	T116,T123	C3887831
27794108	11	20	biomarker	T201	C0005516
27794108	25	50	mitochondrial translation	T045	C2245743
27794108	55	60	mtDNA	T114,T123	C0012929
27794108	61	72	maintenance	T052	C0024501
27794108	73	82	disorders	T047	C0012634
27794108	99	121	mitochondrial myopathy	T019,T047	C0162670
27794108	122	127	serum	T031	C0229671
27794108	128	138	biomarkers	T201	C0005516
27794108	143	157	diagnostic use	T060	C0011933
27794108	162	170	analyzed	T062	C0936012
27794108	171	176	serum	T031	C0229671
27794108	177	182	FGF21	T116,T123	C3887831
27794108	184	191	S-FGF21	T116,T123	C3887831
27794108	197	202	GDF15	T116,T123	C1431343
27794108	208	216	patients	T101	C0030705
27794108	226	248	mitochondrial diseases	T047	C0751651
27794108	257	283	nonmitochondrial disorders	T047	C0012634
27794108	284	293	partially	T081	C0728938
27794108	294	305	overlapping	T079	C1948020
27794108	311	333	mitochondrial disorder	T047	C0751651
27794108	334	344	phenotypes	T032	C0031437
27794108	359	372	meta-analysis	T062	C0920317
27794108	376	383	S-FGF21	T116,T123	C3887831
27794108	387	408	mitochondrial disease	T047	C0751651
27794108	417	425	analyzed	T062	C0936012
27794108	426	433	S-Fgf21	T116,T123	C3887831
27794108	438	453	skeletal muscle	T024	C0242692
27794108	454	459	Fgf21	T116,T123	C3887831
27794108	460	470	expression	T045	C0017262
27794108	476	481	mouse	T015	C0025929
27794108	482	488	models	T008	C0599779
27794108	494	503	different	T080	C1705242
27794108	504	510	muscle	T024	C0026845
27794108	513	524	manifesting	T169	C0205319
27794108	525	551	mitochondrial dysfunctions	T033	C4021734
27794108	568	575	S-FGF21	T116,T123	C3887831
27794108	589	598	increases	T169	C0442805
27794108	602	609	primary	T080	C0205225
27794108	610	632	mitochondrial myopathy	T019,T047	C0162670
27794108	648	656	patients	T101	C0030705
27794108	662	687	mitochondrial translation	T045	C2245743
27794108	688	695	defects	T019	C0000768
27794108	699	734	mitochondrial DNA (mtDNA) deletions	T033	C4313882
27794108	769	777	controls	T096	C0009932
27794108	835	839	mice	T015	C0025929
27794108	841	856	mtDNA deletions	T033	C4313882
27794108	899	907	patients	T101	C0030705
27794108	912	916	mice	T015	C0025929
27794108	922	985	structural respiratory chain subunit or assembly factor defects	T019	C0000768
27794108	993	996	low	T080	C0205251
27794108	997	1006	induction	T169	C0205263
27794108	1008	1013	human	T016	C0086418
27794108	1035	1039	mice	T015	C0025929
27794108	1051	1066	not significant	T033	C1273937
27794108	1069	1076	Overall	T080	C1561607
27794108	1077	1090	specificities	T081	C0037791
27794108	1094	1099	FGF21	T116,T123	C3887831
27794108	1104	1109	GDF15	T116,T123	C1431343
27794108	1118	1126	patients	T101	C0030705
27794108	1132	1154	mitochondrial myopathy	T019,T047	C0162670
27794108	1180	1193	sensitivities	T081	C1511883
27794108	1234	1239	GDF15	T116,T123	C1431343
27794108	1244	1253	increased	T081	C0205217
27794108	1278	1305	nonmitochondrial conditions	T080	C0348080
27794108	1307	1314	S-FGF21	T116,T123	C3887831
27794108	1320	1328	specific	T080	C0205369
27794108	1329	1338	biomarker	T201	C0005516
27794108	1343	1349	muscle	T024	C0026845
27794108	1352	1363	manifesting	T169	C0205319
27794108	1364	1371	defects	T019	C0000768
27794108	1375	1400	mitochondrial translation	T045	C2245743
27794108	1412	1425	mitochondrial	T026	C0026237
27794108	1426	1438	transfer-RNA	T114,T123	C0035711
27794108	1439	1448	mutations	T045	C0026882
27794108	1453	1460	primary	T080	C0205225
27794108	1465	1474	secondary	T080	C0175668
27794108	1475	1490	mtDNA deletions	T033	C4313882
27794108	1508	1514	causes	T169	C0015127
27794108	1518	1539	mitochondrial disease	T047	C0751651
27794108	1550	1556	normal	T080	C0205307
27794108	1557	1564	S-FGF21	T116,T123	C3887831
27794108	1570	1573	not	T033	C1513916
27794108	1574	1581	exclude	T169	C0332196
27794108	1582	1645	structural respiratory chain complex or assembly factor defects	T019	C0000768
27794108	1675	1686	diagnostics	T060	C0430022
27794108	1693	1698	study	T062	C2603343
27794108	1708	1717	Class III	T170	C0441887
27794108	1718	1726	evidence	T078	C3887511
27794108	1732	1740	elevated	T080	C3163633
27794108	1741	1748	S-FGF21	T116,T123	C3887831
27794108	1774	1782	patients	T101	C0030705
27794108	1788	1812	mitochondrial myopathies	T019,T047	C0162670
27794108	1818	1826	patients	T101	C0030705
27794108	1838	1848	conditions	T080	C0348080
27794108	1854	1859	FGF21	T116,T123	C3887831
27794108	1864	1869	GDF15	T116,T123	C1431343
27794108	1870	1892	mitochondrial myopathy	T019,T047	C0162670
27794108	1904	1914	myopathies	T047	C0026848